Literature DB >> 2508061

Immunoglobulin kappa light chain gene promoter and enhancer are not responsible for B-cell restricted gene rearrangement.

M Goodhardt1, C Babinet, G Lutfalla, S Kallenbach, P Cavelier, F Rougeon.   

Abstract

We have produced transgenic mice which synthesize chimeric mouse-rabbit immunoglobulin (Ig) kappa light chains following in vivo recombination of an injected unrearranged kappa gene. The exogenous gene construct contained a mouse germ-line kappa variable (V kappa) gene segment, the mouse germ-line joining (J kappa) locus including the enhancer, and the rabbit b9 constant (C kappa) region. A high level of V-J recombination of the kappa transgene was observed in spleen of the transgenic mice. Surprisingly, a particularly high degree of variability in the exact site of recombination and the presence of non germ-line encoded nucleotides (N-regions) were found at the V-J junction of the rearranged kappa transgene. Furthermore, unlike endogenous kappa genes, rearrangement of the exogenous gene occurred in T-cells of the transgenic mice. These results show that additional sequences, other than the heptamer-nonamer signal sequences and the promoter and enhancer elements, are required to obtain stage- and lineage- specific regulation of Ig kappa light chain gene rearrangement in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508061      PMCID: PMC334819          DOI: 10.1093/nar/17.18.7403

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  24 in total

1.  Developmentally controlled and tissue-specific expression of unrearranged VH gene segments.

Authors:  G D Yancopoulos; F W Alt
Journal:  Cell       Date:  1985-02       Impact factor: 41.582

Review 2.  Regulation of the assembly and expression of variable-region genes.

Authors:  G D Yancopoulos; F W Alt
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

3.  B lymphocyte-specific protein binding near an immunoglobulin kappa-chain gene J segment.

Authors:  D Weaver; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

4.  Recombination between immunoglobulin variable region gene segments is enhanced by transcription.

Authors:  T K Blackwell; M W Moore; G D Yancopoulos; H Suh; S Lutzker; E Selsing; F W Alt
Journal:  Nature       Date:  1986 Dec 11-17       Impact factor: 49.962

5.  Extrachromosomal DNA substrates in pre-B cells undergo inversion or deletion at immunoglobulin V-(D)-J joining signals.

Authors:  J E Hesse; M R Lieber; M Gellert; K Mizuuchi
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

6.  Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells.

Authors:  S V Desiderio; G D Yancopoulos; M Paskind; E Thomas; M A Boss; N Landau; F W Alt; D Baltimore
Journal:  Nature       Date:  1984 Oct 25-31       Impact factor: 49.962

7.  Increased frequency of N-region insertion in a murine pre-B-cell line infected with a terminal deoxynucleotidyl transferase retroviral expression vector.

Authors:  N R Landau; D G Schatz; M Rosa; D Baltimore
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

8.  Rearrangement of a chicken immunoglobulin gene occurs in the lymphoid lineage of transgenic mice.

Authors:  D Bucchini; C A Reynaud; M A Ripoche; H Grimal; J Jami; J C Weill
Journal:  Nature       Date:  1987 Mar 26-Apr 1       Impact factor: 49.962

9.  Rearrangement and expression of rabbit immunoglobulin kappa light chain gene in transgenic mice.

Authors:  M Goodhardt; P Cavelier; M A Akimenko; G Lutfalla; C Babinet; F Rougeon
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

10.  Introduced T cell receptor variable region gene segments recombine in pre-B cells: evidence that B and T cells use a common recombinase.

Authors:  G D Yancopoulos; T K Blackwell; H Suh; L Hood; F W Alt
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

View more
  9 in total

1.  The importance of the 3'-enhancer region in immunoglobulin kappa gene expression.

Authors:  K B Meyer; M J Sharpe; M A Surani; M S Neuberger
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

Review 2.  Transgenic regulation in laboratory animals.

Authors:  S Rusconi
Journal:  Experientia       Date:  1991-09-15

3.  Coordinate transcription and V(D)J recombination of the kappa immunoglobulin light-chain locus: NF-kappaB-dependent and -independent pathways of activation.

Authors:  D P O'Brien; E M Oltz; B G Van Ness
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

4.  Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions.

Authors:  R Fulton; B Van Ness
Journal:  Nucleic Acids Res       Date:  1993-10-25       Impact factor: 16.971

5.  A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.

Authors:  M C Roque; P A Smith; V C Blasquez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

6.  A transgenic mouse that expresses a diversity of human sequence heavy and light chain immunoglobulins.

Authors:  L D Taylor; C E Carmack; S R Schramm; R Mashayekh; K M Higgins; C C Kuo; C Woodhouse; R M Kay; N Lonberg
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

7.  Influence of CpG methylation and target spacing on V(D)J recombination in a transgenic substrate.

Authors:  P Engler; A Weng; U Storb
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

8.  Evidence of antigen receptor-influenced oligoclonal B lymphocyte expansion in the synovium of a patient with longstanding rheumatoid arthritis.

Authors:  S K Lee; S L Bridges; P M Kirkham; W J Koopman; H W Schroeder
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

9.  V(D)J recombination in B cells is impaired but not blocked by targeted deletion of the immunoglobulin heavy chain intron enhancer.

Authors:  M Serwe; F Sablitzky
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.